Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Qbtech
Stockholm, Sweden
- Ownership
- Private
- Development stage
- Other
01
Overview
Qbtech’s QbTest and QbCheck are FDA-cleared and CE marked digital diagnostic tools for objective ADHD assessment and treatment monitoring; these are clinically validated, in use in Europe and US, with >1 million patients tested, and recommended by NICE for UK practice[1][2][4][5].
- Therapeutic areas
- Psychiatry
- Modalities
- DeviceNon-pharmacological therapy
- Industry
- Digital Health Medical Devices
02
Partnerships
NHS England Academic Health Science Network (AHSN)NICEVerdane (growth partner)
Beyond the preview
Go deeper on Qbtech.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Qbtech.